PT - JOURNAL ARTICLE AU - Souza, Alexandra Brito AU - B. Arriaga, María AU - Amorim, Gustavo AU - Araújo-Pereira, Mariana AU - M. F. Nogueira, Betânia AU - Queiroz, Artur T. L. AU - Figueiredo, Marina C. AU - Rocha, Michael S. AU - Benjamin, Aline AU - Moreira, Adriana S. R. AU - de Oliveira, Jamile G. AU - Rolla, Valeria C. AU - Durovni, Betina AU - Lapa e Silva, José R. AU - Kritski, Afrânio L. AU - Cavalcante, Solange AU - Sterling, Timothy R. AU - Andrade, Bruno B. AU - Cordeiro-Santos, Marcelo AU - , TI - Determinants of losses in the latent tuberculosis infection cascade of care in Brazil: a prospective multicenter cohort study AID - 10.1101/2021.03.12.21252212 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.12.21252212 4099 - http://medrxiv.org/content/early/2021/03/15/2021.03.12.21252212.short 4100 - http://medrxiv.org/content/early/2021/03/15/2021.03.12.21252212.full AB - Background Factors associated with losses in the latent tuberculosis infection (LTBI) cascade of care in contacts of tuberculosis (TB) patients were investigated in a multicenter prospective cohort from highly endemic regions in Brazil.Methods Close contacts of 1,187 culture-confirmed pulmonary TB patients were prospectively studied between 2015 and 2019, with follow-up between 6 and 24 months. Data on TB screening by clinical investigation, radiographic examination and interferon-gamma release assay (IGRA) were collected. Stepwise multivariable models were used to identify determinants of losses in the LTBI cascade.Results Among 4,145 TB contacts initially identified, 1,901 were examined (54% loss). Within those individuals, 933 were people living with HIV, ≤5 years-old and/or had positive IGRA results, therefore having recommendation to start TB preventive treatment (TPT). Of those, 454 (23%) initiated treatment, and 247 (6% of all TB contacts) completed TPT. Multivariable regression analysis revealed that living with HIV, illiteracy, and black/pardo (brown) race were independently associated with losses in cascade.Conclusion There were losses at all LTBI cascade stages, but particularly at the initial screening and examination steps. Close contacts who are socially vulnerable and living with HIV were at heightened risk of not completing the LTBI cascade of care in Brazil.40-word summary of the article’s main point We investigated factors associated with losses in the latent tuberculosis infection cascade of care in a large cohort of contacts in Brazil. Social vulnerability and HIV infection were the most relevant determinants of losses in the LTBI cascade of care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the Intramural Research Program of the Fundaccao Oswaldo Cruz (B.B.A.), Intramural Research Program of the Fundacao Jose Silveira (B.B.A., M.S.R., B.M.F.N.), Departamento de Ciencia e Tecnologia (DECIT) - Secretaria de Ciencia e Tecnologia (SCTIE), Ministerio da Saude (MS), Brazil [25029.000507/2013-07 to V.C.R.] and the National Institutes of Allergy and Infectious Diseases [U01-AI069923 to T.R.S, ABS, MBA, GA, BMFN, ATLQ, MCF, MSR, AB, ASRM, JGO, VCR, BD, JRLS, ALK, SC, TRS, BBA, and MCS and U01-AI115940 to B.B.A.]. M.B.A. received a fellowship from the Fundacao de Amparo a Pesquisa da Bahia (FAPESB). MAP received a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Finance code: 001). B.B.A, and A.K. are senior investigators whereas A.B.S. is a PhD fellow from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders of the study had no role in study design, data analysis, data interpretation, or writing of the report. All authors had access to all the data in the study and had final responsibility for the decision to submit for publication. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol, informed consent, and study documents were approved by the institutional review boards at all study sites. The Institional Review Boards and the protocol approval numbers are as follows: (i) Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil (protocol no. 688.067), (ii) Secretaria Municipal de Saude do Rio de Janeiro, Brazil (protocol no. 740.554), (iii) Hospital Universitario Clementino Fraga Filho Rio de Janeiro, Brazil (protocol no. 852.519), (iv) Maternidade Climerio de Oliveira, Universidade Federal da Bahia, Salvador, Brazil (protocol no. 723.168), (v) Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil (protocol no. 807.595). Participation was voluntary and written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is available through contact with the corresponding author.